| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/11/2006 | CN1235890C Thizaolyl amide derivatives |
| 01/11/2006 | CN1235884C Antifungal compound of substitution benzyl triazole alcohols and preparing process thereof |
| 01/11/2006 | CN1235644C Preparing process of antibacterial nanometer silver powder contained externally applied dressing |
| 01/11/2006 | CN1235606C Vaginitis-treating compound Chinese and Western medicine preparation |
| 01/11/2006 | CN1235603C Dry rhizopus bacteria suspension, its prepn process and use |
| 01/11/2006 | CN1235601C Extractive of ocean star worm, its preparing method and application |
| 01/11/2006 | CN1235599C Arsenic compound recipe for treating tuberculosis and dermatopathy |
| 01/11/2006 | CN1235592C Glycyrrhizin triple composition nano micro particle and its preparing method |
| 01/11/2006 | CN1235591C Composition for preventing and treating yellow dysentery of piglet |
| 01/11/2006 | CN1235588C Almitil intravenous injection and its preparing method |
| 01/11/2006 | CN1235585C Use of berberine as anti fungus medicine synergist |
| 01/11/2006 | CN1235584C Sustained release tablet of matrine and its preparing method |
| 01/11/2006 | CN1235583C Benzimidazole derivatives as therapeutic agents |
| 01/10/2006 | US6984721 Immunological reagents and diagnostic methods for the detection of human immunodeficiency virus type 2 utilizing multimeric forms of the envelope proteins GP300, P200, and P90/80 |
| 01/10/2006 | US6984720 cytotoxic t lymphocytes; immunology |
| 01/10/2006 | US6984654 Cancer treatments and pharmaceutical compositions therefor |
| 01/10/2006 | US6984653 useful as a growth factor receptor tyrosine kinase HER2 (Human epidermal growth factor receptor-2) inhibitor; for treating cancer |
| 01/10/2006 | US6984652 useful for the treatment or prophylaxis of bacterial infections in mammals |
| 01/10/2006 | US6984651 Piperidine amides as modulators of chemokine receptor activity |
| 01/10/2006 | US6984649 Pyridine derivatives |
| 01/10/2006 | US6984648 TNF (tumor necrosis factor); for treating conditions such as rheumatoid and osteoarthritis, corneal, epidermal or gastric ulceration; tumor metastasis or invasion; periodontal disease and bone disease |
| 01/10/2006 | US6984490 Identification of genes |
| 01/10/2006 | US6984403 Azithromycin dosage forms with reduced side effects |
| 01/10/2006 | US6984397 Encapsulated pipecolic acid; immunosuppressants |
| 01/10/2006 | US6984391 Mixture containing ammonium salt; gradient adjustment of pH; skin disorders, acne |
| 01/10/2006 | US6984385 Immunological combination compositions and methods |
| 01/10/2006 | US6984384 A biodrug mixture contains a preheated fusion protein,comprising heat shock protein, glucose-regulated protein and immuogens; antigrowth agents; cancer, tuberculosis infection |
| 01/10/2006 | CA2372206C Novel crystalline forms of a macrolide antibiotic |
| 01/10/2006 | CA2370411C Diazabicyclo compounds for the treatment of schizophrenia and other disorders |
| 01/10/2006 | CA2364178C N-benzenesulfonyl l-proline compounds as bradykinin antagonists |
| 01/10/2006 | CA2327758C (4-arylsulfonylamino)-tetrahydropyran-4-carboxylic acid hydroxamides |
| 01/10/2006 | CA2189831C Dna-based vaccination of fish by immersion |
| 01/10/2006 | CA2163520C L-2',3'-dideoxy nucleoside analogs as anti-hepatitis b (hbv) and anti-hiv agents |
| 01/10/2006 | CA2157590C Use of terbinafine for the therapeutic treatment of pneumocystosis |
| 01/05/2006 | WO2006001733A1 Tuberculosis treating and preventing agent |
| 01/05/2006 | WO2004080976A8 Phthalazinone derivatives |
| 01/05/2006 | US20060004063 Inhibitors of HCV NS5B polymerase |
| 01/05/2006 | US20060004056 Di-aryl-substituted-ethan pyridone pde4 inhibitors |
| 01/05/2006 | US20060004054 Administering 1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindoline before or at the time angioplasty, coronary by-pass grafting or stent implantation |
| 01/05/2006 | US20060004025 Arylamine substututed bicyclic heteroaromatic compounds as p38 kinase inhibitors |
| 01/05/2006 | US20060004010 Ccr4 antagonist and medical use thereof |
| 01/05/2006 | US20060004000 N-aryl-5-substituted-3-yl-1H-indazole-3-carboxamides; amidation of the 1-protected-1H-indazole-3-carboxylic acid, deblocking; hypotensive agents |
| 01/05/2006 | US20060003987 Compounds and their uses |
| 01/05/2006 | US20060003984 Monobactam compositions and methods of use thereof |
| 01/05/2006 | US20060003975 Combination of an aldosterone receptor antagonist and an HMG CoA reductase inhibitor |
| 01/05/2006 | US20060003962 Methods and products related to treatment and prevention of hepatitis C virus infection |
| 01/05/2006 | US20060003955 Immunostimulatory nucleic acid molecules |
| 01/05/2006 | US20060003951 Anti-viral 7-deaza L-nucleosides |
| 01/05/2006 | US20060003922 Spinner preparation machine and cavity resonator |
| 01/05/2006 | US20060003451 Cell lines and constructs useful in production of E1-deleted adenoviruses in absence of replication competent adenovirus |
| 01/05/2006 | US20060003378 Expressed by keratinocytes, wound-healing and chondrosarcoma tissue; nucleic acids comprising polynucleotide of given sequence; use in diagnostics and therapeutics |
| 01/05/2006 | US20060002991 Ph-sensitive cationic lipids, and liposomes and nanocapsules containing the same |
| 01/05/2006 | US20060002961 Immunogens; Streptococcus pneumoniae polysaccharide-protein conjugate/antigen, and adjuvant which induces (cytotoxic T) lymphocytes |
| 01/05/2006 | US20060002958 Attenuation of metapneumovirus |
| 01/05/2006 | US20060002951 Inhibition of the tRNALys3-primed initiation of reverse transcription in HIV-1 by APOBEC3G |
| 01/05/2006 | US20060002939 Monoclonal and chimeric antibodies that bind to lipoteichoic acid of Gram positive bacteria. The antibodies also bind to whole bacteria and enhance phagocytosis and killing of the bacteria in vitro and enhance protection from lethal; light and heavy chains comprising complementarity determining regions |
| 01/05/2006 | US20060002910 Agent for the anti-adhesion of skin pathogenic flora |
| 01/05/2006 | US20060002908 Bifidobacterium in the treatment of inflammatory disease |
| 01/05/2006 | US20060002905 Mutant forms of EtxB and CtxB and their use as carriers |
| 01/05/2006 | US20060002893 Targeted adenovirus vectors for delivery of heterologous genes |
| 01/05/2006 | US20060002887 Ionene oligomers and polymers |
| 01/05/2006 | DE102004028899A1 Mittel zur Steigerung der Aktivität der sekretorischen Phospholipase A2-IIA Means for enhancing the activity of the secretory phospholipase A2-IIA |
| 01/05/2006 | DE102004004901B4 Verfahren zur Herstellung von Sorbicillacton A A process for the preparation of sorbicillacton |
| 01/05/2006 | CA2571949A1 Modulators of atp-binding cassette transporters |
| 01/05/2006 | CA2571849A1 Anticancer agent containing dendritic cell having rna virus transferred thereinto |
| 01/05/2006 | CA2571844A1 Anticancer agent containing minus-strand rna virus |
| 01/05/2006 | CA2571675A1 5-aza-7-deazapurine derivatives for treating infections with flaviviridae |
| 01/05/2006 | CA2571558A1 Novel uses of porphyrin compounds |
| 01/05/2006 | CA2571421A1 Compounds for immunopotentiation |
| 01/05/2006 | CA2571183A1 Composition comprising lactic acid and lactoferrin |
| 01/05/2006 | CA2570778A1 Prrsv subunit vaccines |
| 01/04/2006 | EP1612270A2 Rétroviral nucleic material and nucleotide fragments, in particular associated with multiple sclerosis and/or rheumatoid arthritis, for diagnostic, prophylactic and therapeutic uses |
| 01/04/2006 | EP1612269A1 Use of replication-deficient adenoviral vector to boost CD8+ T cell immune response to antigen |
| 01/04/2006 | EP1612211A1 Novel carbapenem compounds |
| 01/04/2006 | EP1612204A1 Hydrazone derivative |
| 01/04/2006 | EP1611894A1 Use of n-acetyl-d-aminoglycosamine in treatment of non-specific inflammations related to physical or chemical factors |
| 01/04/2006 | EP1611889A1 Antibacterial agent and anticancer agent |
| 01/04/2006 | EP1611885A1 Use of an inducing agent for the treatment of blood, viral and cellular disorders |
| 01/04/2006 | EP1611883A1 Composition for ophthalmic use |
| 01/04/2006 | EP1611155A2 Method and compositions for conversion of antibody activity |
| 01/04/2006 | EP1611136A2 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto |
| 01/04/2006 | EP1611127A2 4-substitued quinolein derivatives with antimicrobial activity |
| 01/04/2006 | EP1611105A1 Isoquinoline-5-sulfonic acid amides as inhibitors of akt (protein kinase b) |
| 01/04/2006 | EP1611092A1 Pleuromutilin derivatives, process for their preparation and uses thereof |
| 01/04/2006 | EP1610815A2 Francisella strain for live vaccine |
| 01/04/2006 | EP1610799A1 Compositions comprising hyaluronic acid for the prevention of urogenital infections |
| 01/04/2006 | EP1610797A1 Antiviral combination of nevirapine and a further antiretroviral compound |
| 01/04/2006 | EP1610782A1 Antiviral combination of a dipyridodiazepinone and a further antiretroviral compound |
| 01/04/2006 | EP1610781A1 Antiviral combination of tipranavir and a further antiretroviral compound |
| 01/04/2006 | EP1610759A2 Substituted quinobenzoxazine analogs |
| 01/04/2006 | EP1536800B1 Synergistic interaction of abacavir and alovudine |
| 01/04/2006 | EP1494658B1 Natural phenolic products and derivatives thereof for protection against neurodegenerative diseases |
| 01/04/2006 | EP1395585B1 Antibacterial agents |
| 01/04/2006 | EP1363873A4 Peptide deformylase inhibitors |
| 01/04/2006 | EP1311677B1 Regulation of human p2y1-like g protein-coupled receptor |
| 01/04/2006 | EP1250422B1 Myeloid colony stimulating factor and uses thereof |
| 01/04/2006 | EP1206476B1 9a-azalides with antibacterial activity |
| 01/04/2006 | EP1169298B1 Pharmaceutical compounds |
| 01/04/2006 | EP1149116B1 Process for the production of multiple cross-linked hyaluronic acid derivatives |
| 01/04/2006 | EP1146881B1 Preparation for the prevention and/or treatment of a tissue change of mesenchymal origin |